Align TechnologyXTER:AFW 89 PEG Ratio is 2.14 as of Jul. 01, 2026, which is 10% below its 10-year median of 2.38. GuruFocus rates XTER:AFW with a GF Score™ of 89/100 and a GF Value™ of €211.85 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Align Technology ranks worse than 51.69% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Align Technology's PEG Ratio or its related term are showing as below:
XTER:AFW'
s PEG Ratio Range Over the Past 10 Years
Min: 0.88 Med: 2.38 Max: 10.69
Current: 2.08
During the past 13 years, Align Technology's highest PEG Ratio was 10.69. The lowest was 0.88. And the median was 2.38.
XTER:AFW's PEG Ratio is ranked worse than 51.69% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs XTER:AFW: 2.08
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Align Technology (XTER:AFW) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Align Technology PEG Ratio Related Terms
Align Technology PEG Ratio Historical Data
* Premium members only.
The historical data trend for Align Technology's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Align Technology's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Align Technology's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Align Technology (XTER:AFW) has a PEG Ratio of 2.14 as of Jul. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Align Technology and its competitors. This is 10% below median its historical median of 2.38. Over the past decade, Align Technology's PEG Ratio has ranged from 0.88 to 10.69. According to the industry distribution chart, Align Technology ranks #107 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 51.7%.
Is Align Technology's PEG Ratio too high?
Align Technology's current PEG Ratio of 2.14 is 10% below median its 10-year median of 2.38. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 10.69. The Medical Devices & Instruments industry median PEG Ratio is 2.03. Align Technology's value of 2.14 is 5.4% above this industry median. Based on the distribution chart, Align Technology ranks #107 out of 207 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Align Technology has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's PEG Ratio compare to SOLV and COO?
According to the Medical Devices & Instruments industry distribution chart, Align Technology ranks #107 out of 207 companies for PEG Ratio. This places Align Technology in the lower half of its industry. The industry median PEG Ratio is 2.03. Align Technology's value of 2.14 is 5.4% above this benchmark. Historically, Align Technology's own PEG Ratio has ranged from 0.88 to 10.69 over the past decade. While the company's 10-year median is 2.38 vs. the industry median of 2.03, Align Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Align Technology's current PEG Ratio of 2.14 is 5.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Align Technology and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Align Technology's current PEG Ratio is 2.14, which is 10% below median its own 10-year median of 2.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (XTER:AFW) is currently considered Significantly Undervalued. The stock's GF Value™ is €211.85, compared to a current price of €149.05 — trading 29.6% below its estimated fair value. The current PEG Ratio is 2.14, which is 10% below median its 10-year median of 2.38 and 5.4% above the Medical Devices & Instruments industry median of 2.03. Align Technology's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Align Technology (XTER:AFW), the current PEG Ratio is 2.14 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Align Technology (XTER:AFW) Overvalued in 2026?
Based on GuruFocus' analysis, Align Technology stock appears to be undervalued.
The current stock price of €149.05 is trading 29.6% below its estimated GF Value™ of €211.85.
GuruFocus considers Align Technology to be Significantly Undervalued.
Key valuation signals for XTER:AFW:
PEG Ratio: 2.14 (10% below median its 10-year median of 2.38)
GF Value™: €211.85 vs. price of €149.05 (29.6% below fair value)
Industry Position: 5.4% above the Medical Devices & Instruments median (#107 of 207)
No single metric tells the full story. See the XTER:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
89GF Score
Get the complete analysis for XTER:AFW
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AFW has been successfully added to your 
